Welcome

Despite remarkable advances in the fight against cancer in the past several decades, certain malignancies display remarkable genetic, epigenetic and metabolic plasticity, culminating in resistance to even the most aggressive therapeutic modalities.  It has long been recognized that stresses present in the tumor microenvironment (TME), including hypoxia, low nutrient availability, the presence or absence of specific immune infiltrates, the microbiome ecosystem etc., act as physiological selective pressures that promote tumor aggressiveness and confound therapeutic efforts. Gaining further key insights into the complex interactions between tumor cells, stromal components, immune cells, and the extracellular matrix can provide new approaches and targets to widen the therapeutic window and improve outcomes in oncology.

The overarching goal of this conference is to bring together distinguished experts, leading scientists, and trainees in this burgeoning field to discuss ground-breaking discoveries, transformative new concepts, and promising technologies that have the potential to usher new paths to therapeutic intervention.  We aim to stimulate collaboration between groups working on cellular and molecular aspects of TME biology at the with groups that are engaged in drug discovery, development of innovative imaging modalities or are engaged in oncology clinical trials.

Important Dates

• Abstract Deadline: TBA
• Conference dates:  26-31 October, 2026

Latest News

• Website launch: 05 May, 2025